Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in HIV Med

Retrieve available abstracts of 107 articles:
HTML format
Text format



Single Articles


    October 2018
  1. CHEN J, Zhang R, Shen Y, Liu L, et al
    Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV-infected patients with cryptococcal meningitis.
    HIV Med. 2018 Oct 12. doi: 10.1111/hiv.12679.
    PubMed     Text format     Abstract available


    September 2018
  2. WIJTING I, Rutsaert SL, Rokx C, Burger DM, et al
    Predictors of virological failure in HIV-1-infected patients switching to dolutegravir maintenance monotherapy.
    HIV Med. 2018 Sep 30. doi: 10.1111/hiv.12675.
    PubMed     Text format     Abstract available


  3. ASTON SJ, Doherty K, Black B, Davies G, et al
    Latent tuberculosis infection screening in HIV-infected patients: guidelines versus everyday practice in a UK HIV centre.
    HIV Med. 2018 Sep 30. doi: 10.1111/hiv.12678.
    PubMed     Text format    


  4. BALDE A, Lievre L, Maiga AI, Diallo F, et al
    Risk factors for loss to follow-up, transfer or death among people living with HIV on their first antiretroviral therapy regimen in Mali.
    HIV Med. 2018 Sep 30. doi: 10.1111/hiv.12668.
    PubMed     Text format     Abstract available


  5. KNUDSEN A, Kristoffersen US, Panum I, Hansen YB, et al
    Coronary artery calcium and intima-media thickness are associated with level of cytomegalovirus immunoglobulin G in HIV-infected patients.
    HIV Med. 2018 Sep 4. doi: 10.1111/hiv.12672.
    PubMed     Text format     Abstract available


  6. MARCUS JL, Hurley LB, Prasad A, Zaroff J, et al
    Recurrence after hospitalization for acute coronary syndrome among HIV-infected and HIV-uninfected individuals.
    HIV Med. 2018 Sep 4. doi: 10.1111/hiv.12670.
    PubMed     Text format     Abstract available


    August 2018
  7. JASPAL R, Lopes B, Bayley J, Papaloukas P, et al
    A structural equation model to predict pre-exposure prophylaxis acceptability in men who have sex with men in Leicester, UK.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12667.
    PubMed     Text format     Abstract available


  8. AURPIBUL L, Sugandhavesa P, Srithanaviboonchai K, Sitthi W, et al
    Peripheral artery disease in HIV-infected older adults on antiretroviral treatment in Thailand.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12671.
    PubMed     Text format     Abstract available


  9. THUDIUM RF, Lundgren J, Benfield T, Nordestgaard BG, et al
    HIV infection is independently associated with a higher concentration of alpha-1 antitrypsin.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12666.
    PubMed     Text format     Abstract available


  10. KIEFER EM, Hoover DR, Shi Q, Dusingize JC, et al
    Longitudinal evaluation of markers of inflammation in HIV-positive and HIV-negative Rwandan women.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12665.
    PubMed     Text format     Abstract available


  11. RONIT A, Benfield T, Mocroft A, Gerstoft J, et al
    Diagnostic performance of clinical characteristics to detect airflow limitation in people living with HIV and in uninfected controls.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12669.
    PubMed     Text format     Abstract available


  12. DEWAR C, Anstee QM, Price DA, Payne B, et al
    Central obesity and nonalcoholic fatty liver disease in people living with HIV: a case for targeted screening?
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12674.
    PubMed     Text format    


  13. FENTON K, Cropp A, Chauhan M, Foster K, et al
    Earlier diagnosis of HIV infection through visual HIV testing prompts.
    HIV Med. 2018 Aug 30. doi: 10.1111/hiv.12673.
    PubMed     Text format    


  14. HAGINS D, Orkin C, Daar ES, Mills A, et al
    Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96-week results from two randomized clinical trials.
    HIV Med. 2018 Aug 12. doi: 10.1111/hiv.12664.
    PubMed     Text format     Abstract available


  15. LAM JO, Barnell GM, Merchant M, Ellis CG, et al
    Acceptability of high-resolution anoscopy for anal cancer screening in HIV-infected patients.
    HIV Med. 2018 Aug 6. doi: 10.1111/hiv.12663.
    PubMed     Text format     Abstract available


  16. SEERS T, Vassallo P, Pollock K, Thornhill JP, et al
    CD4:CD8 ratio in children with perinatally acquired HIV-1 infection.
    HIV Med. 2018 Aug 6. doi: 10.1111/hiv.12642.
    PubMed     Text format     Abstract available



  17. Welcome Letter.
    HIV Med. 2018;19 Suppl 3:3.
    PubMed     Text format    


  18. SMITH DE, Woolley IJ, Russell DB, Bisshop F, et al
    HIV in practice: current approaches and challenges in the diagnosis, treatment and management of HIV infection in Australia.
    HIV Med. 2018;19 Suppl 3:5-23.
    PubMed     Text format     Abstract available


    July 2018
  19. NASSEREDDINE H, Charpentier C, Bucau M, Joly V, et al
    Interest of cytology combined with Xpert((R)) HPV and Anyplex((R)) II HPV28 Detection human papillomavirus (HPV) typing: differential profiles of anal and cervical HPV lesions in HIV-infected patients on antiretroviral therapy.
    HIV Med. 2018 Jul 30. doi: 10.1111/hiv.12661.
    PubMed     Text format     Abstract available


  20. KUSEJKO K, Marzel A, Hampel B, Bachmann N, et al
    Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in Switzerland.
    HIV Med. 2018 Jul 26. doi: 10.1111/hiv.12660.
    PubMed     Text format     Abstract available


  21. IRELAND G, Delpech V, Kirwan P, Croxford S, et al
    Prevalence of diagnosed HIV infection among persons with hepatitis C virus infection: England, 2008-2014.
    HIV Med. 2018 Jul 26. doi: 10.1111/hiv.12662.
    PubMed     Text format     Abstract available


  22. HATLEBERG CI, Ryom L, d'Arminio Monforte A, Fontas E, et al
    Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
    HIV Med. 2018 Jul 18. doi: 10.1111/hiv.12639.
    PubMed     Text format     Abstract available


  23. ACOSTA MC, Kundro M, Viloria G, Peresin A, et al
    The role of brain biopsy in the clinical management of HIV-related focal brain lesions.
    HIV Med. 2018 Jul 13. doi: 10.1111/hiv.12646.
    PubMed     Text format     Abstract available


  24. GALLIEN S, Massetti M, Flandre P, Leleu H, et al
    Comparison of 48-week efficacies of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimens: a systematic review and network meta-analysis.
    HIV Med. 2018 Jul 13. doi: 10.1111/hiv.12643.
    PubMed     Text format     Abstract available


  25. SCHOLTEN M, Suarez I, Platten M, Kummerle T, et al
    To prescribe, or not to prescribe: decision making in HIV-1 post-exposure prophylaxis.
    HIV Med. 2018 Jul 11. doi: 10.1111/hiv.12645.
    PubMed     Text format     Abstract available


  26. KOWALSKA JD, Bursa D, Gokengin D, Jilich D, et al
    HIV health care providers are ready to introduce pre-exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.
    HIV Med. 2018 Jul 10. doi: 10.1111/hiv.12641.
    PubMed     Text format     Abstract available


  27. HABERLEN SA, Jacobson LP, Palella FJ Jr, Dobs A, et al
    To T or not to T: Differences in Testosterone Use and Discontinuation by HIV Serostatus among Men who Have Sex with Men.
    HIV Med. 2018 Jul 10. doi: 10.1111/hiv.12644.
    PubMed     Text format     Abstract available


  28. AHLSTROM MG, Knudsen A, Ullum H, Gerstoft J, et al
    Association between smoking status assessed with plasma-cotinine and inflammatory and endothelial biomarkers in HIV-positive and HIV-negative individuals.
    HIV Med. 2018 Jul 9. doi: 10.1111/hiv.12647.
    PubMed     Text format     Abstract available


  29. KRZNARIC I, Bickel M, Carganico A, De Leuw P, et al
    Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 years.
    HIV Med. 2018 Jul 3. doi: 10.1111/hiv.12636.
    PubMed     Text format     Abstract available


  30. HONGLER J, Musaazi J, Ledergerber B, Eberhard N, et al
    Comparison of Lowenstein-Jensen and BACTEC MGIT 960 culture for Mycobacterium tuberculosis in people living with HIV.
    HIV Med. 2018 Jul 3. doi: 10.1111/hiv.12635.
    PubMed     Text format     Abstract available


  31. BROWN LJ, Tan KS, Guerra LE, Naidoo CJ, et al
    Using behavioural insights to increase HIV self-sampling kit returns: a randomized controlled text message trial to improve England's HIV self-sampling service.
    HIV Med. 2018 Jul 2. doi: 10.1111/hiv.12634.
    PubMed     Text format     Abstract available


    June 2018
  32. FABBRI G, Mastrorosa I, Vergori A, Timelli L, et al
    Liver stiffness reduction and serum fibrosis score improvement in HIV/hepatitis C virus-coinfected patients treated with direct-acting antivirals.
    HIV Med. 2018 Jun 28. doi: 10.1111/hiv.12632.
    PubMed     Text format     Abstract available


  33. ROSSETTI B, Di Giambenedetto S, Torti C, Postorino MC, et al
    Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.
    HIV Med. 2018 Jun 22. doi: 10.1111/hiv.12640.
    PubMed     Text format     Abstract available


  34. SCULIER D, Doco-Lecompte T, Yerly S, Metzner KJ, et al
    Stable HIV-1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study.
    HIV Med. 2018 Jun 22. doi: 10.1111/hiv.12626.
    PubMed     Text format     Abstract available


  35. CASADO JL, Santiuste C, Vivancos MJ, Monsalvo M, et al
    Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity.
    HIV Med. 2018 Jun 22. doi: 10.1111/hiv.12630.
    PubMed     Text format     Abstract available


  36. SAGNELLI C, Uberti-Foppa C, Hasson H, Bellini G, et al
    In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infection.
    HIV Med. 2018 Jun 22. doi: 10.1111/hiv.12638.
    PubMed     Text format     Abstract available


  37. BROWN AE, Nash S, Connor N, Kirwan PD, et al
    Towards elimination of HIV transmission, AIDS and HIV-related deaths in the UK.
    HIV Med. 2018 Jun 20. doi: 10.1111/hiv.12617.
    PubMed     Text format     Abstract available


  38. MAO X, Wang Z, Hu Q, Huang C, et al
    HIV incidence is rapidly increasing with age among young men who have sex with men in China: a multicentre cross-sectional survey.
    HIV Med. 2018 Jun 19. doi: 10.1111/hiv.12623.
    PubMed     Text format     Abstract available


  39. CHU DT, Vo Truong Nhu N, Tao Y, Le Hoang S, et al
    Achievements and challenges in HIV/AIDS control in Vietnam.
    HIV Med. 2018 Jun 6. doi: 10.1111/hiv.12631.
    PubMed     Text format    


  40. FOCA E, Cavaglia G, Rusconi S, Cascavilla A, et al
    Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study.
    HIV Med. 2018 Jun 4. doi: 10.1111/hiv.12624.
    PubMed     Text format     Abstract available


  41. HENTZIEN M, Cabie A, Pugliese P, Billaud E, et al
    Factors associated with deaths from suicide in a French nationwide HIV-infected cohort.
    HIV Med. 2018 Jun 1. doi: 10.1111/hiv.12633.
    PubMed     Text format     Abstract available


    May 2018
  42. TARAMASSO L, Di Biagio A, Maggiolo F, Tavelli A, et al
    First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison.
    HIV Med. 2018 May 30. doi: 10.1111/hiv.12628.
    PubMed     Text format     Abstract available


  43. PAKIANATHAN M, Whittaker W, Lee MJ, Avery J, et al
    Chemsex and new HIV diagnosis in gay, bisexual and other men who have sex with men attending sexual health clinics.
    HIV Med. 2018 May 22. doi: 10.1111/hiv.12629.
    PubMed     Text format     Abstract available


  44. GUO F, Cheng X, Hsieh E, Du X, et al
    Prospective plasma efavirenz concentration assessment in Chinese HIV-infected adults enrolled in a large multicentre study.
    HIV Med. 2018 May 15. doi: 10.1111/hiv.12607.
    PubMed     Text format     Abstract available


  45. TRUNFIO M, Vai D, Montrucchio C, Alcantarini C, et al
    Diagnostic accuracy of new and old cognitive screening tools for HIV-associated neurocognitive disorders.
    HIV Med. 2018 May 15. doi: 10.1111/hiv.12622.
    PubMed     Text format     Abstract available


  46. AHMED SI, Hasan SS, Babar MG
    Patients' involvement in the care process: time to value nontraditional indicators in HIV care.
    HIV Med. 2018 May 10. doi: 10.1111/hiv.12620.
    PubMed     Text format    


  47. GONZALEZ-CORDON A, Domenech M, Camafort M, Martinez-Rebollar M, et al
    Subclinical cardiovascular disease in patients starting contemporary protease inhibitors.
    HIV Med. 2018 May 10. doi: 10.1111/hiv.12619.
    PubMed     Text format     Abstract available


  48. CROXFORD S, Yin Z, Kall M, Burns F, et al
    Where do we diagnose HIV infection? Monitoring new diagnoses made in nontraditional settings in England, Wales and Northern Ireland.
    HIV Med. 2018 May 9. doi: 10.1111/hiv.12627.
    PubMed     Text format     Abstract available


  49. JAKOBSEN SF, Raben D, Sperle I, Lazarus JV, et al
    Scale-up of HIV self-testing.
    HIV Med. 2018 May 8. doi: 10.1111/hiv.12618.
    PubMed     Text format    


  50. BROWN AE, Attawell K, Hales D, Rice BD, et al
    Monitoring the HIV continuum of care in key populations across Europe and Central Asia.
    HIV Med. 2018 May 8. doi: 10.1111/hiv.12603.
    PubMed     Text format     Abstract available


    April 2018
  51. CRESSWELL FV, Ellis J, Hartley J, Sabin CA, et al
    A systematic review of risk of HIV transmission through biting or spitting: implications for policy.
    HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12625.
    PubMed     Text format     Abstract available


  52. JIAMSAKUL A, Yunihastuti E, Van Nguyen K, Merati TP, et al
    Mortality following diagnosis of tuberculosis in HIV-infected patients in Asia.
    HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12621.
    PubMed     Text format    


  53. MASIA M, Padilla S, Garcia JA, Bernardino JI, et al
    Decreasing rates of acute myocardial infarction in people living with HIV: a nationwide cohort study in Spain, 2004-2015.
    HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12616.
    PubMed     Text format     Abstract available


  54. GOMPELS M, Michael S, Jose S, Hill T, et al
    The use of funnel plots with regression as a tool to visually compare HIV treatment outcomes between centres adjusting for patient characteristics and size: a UK Collaborative HIV Cohort study.
    HIV Med. 2018 Apr 14. doi: 10.1111/hiv.12604.
    PubMed     Text format     Abstract available



  55. Abstracts of the 4th Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), Edinburgh, UK, 17-20 April 2018.
    HIV Med. 2018;19 Suppl 2:s5-s152.
    PubMed     Text format    


    March 2018
  56. DAUBY N, Martin C, Hainaut M, Grammens T, et al
    Prevalence and risk factors of measles seronegativity in a cohort of HIV-positive subjects: a retrospective study.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12610.
    PubMed     Text format     Abstract available


  57. AEBI-POPP K, Wandeler G, Salazar-Vizcaya L, Metzner K, et al
    Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12602.
    PubMed     Text format     Abstract available


  58. BORGHETTI A, Baldin G, Lombardi F, Ciccullo A, et al
    Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV-1 replication.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12611.
    PubMed     Text format     Abstract available


  59. NIMKAR S, Valvi C, Kadam D, Rewari BB, et al
    Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12605.
    PubMed     Text format     Abstract available


  60. SEZGIN E, Van Natta ML, Thorne JE, Puhan MA, et al
    Secular trends in opportunistic infections, cancers and mortality in patients with AIDS during the era of modern combination antiretroviral therapy.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12609.
    PubMed     Text format     Abstract available


  61. HONGE BL, Jespersen S, Medina C, Te DS, et al
    The challenge of discriminating between HIV-1, HIV-2 and HIV-1/2 dual infections.
    HIV Med. 2018 Mar 24. doi: 10.1111/hiv.12606.
    PubMed     Text format     Abstract available


  62. RYOM L, Boesecke C, Bracchi M, Ambrosioni J, et al
    Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.
    HIV Med. 2018 Mar 1. doi: 10.1111/hiv.12600.
    PubMed     Text format     Abstract available


    February 2018
  63. OPREA C, Ianache I, Calistru PI, Nica M, et al
    Increasing incidence of HIV- associated tuberculosis in Romanian injecting drug users.
    HIV Med. 2018 Feb 21. doi: 10.1111/hiv.12576.
    PubMed     Text format     Abstract available


  64. HAYNES BI, Pitkanen M, Kulasegaram R, Casey SJ, et al
    HIV: ageing, cognition and neuroimaging at 4-year follow-up.
    HIV Med. 2018 Feb 14. doi: 10.1111/hiv.12598.
    PubMed     Text format     Abstract available


  65. SANTOS JR, Cozzi-Lepri A, Phillips A, De Wit S, et al
    Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe.
    HIV Med. 2018 Feb 1. doi: 10.1111/hiv.12581.
    PubMed     Text format     Abstract available


  66. ASPINALL EJ, Hutchinson SJ, Goldberg DJ, Valerio H, et al
    Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
    HIV Med. 2018;19 Suppl 1:11-15.
    PubMed     Text format     Abstract available


  67. RABEN D, Hoekstra M, Sperle I, Amato Gauci AJ, et al
    The HepHIV 2017 Conference in Malta: joining forces for the earlier diagnosis of HIV and viral hepatitis.
    HIV Med. 2018;19 Suppl 1:5-10.
    PubMed     Text format     Abstract available


  68. MEULBROEK M, Pujol F, Perez F, Dalmau-Bueno A, et al
    BCN Checkpoint: same-day confirmation of reactive HIV rapid test with Point Of Care HIV-RNA accelerates linkage to care and reduces anxiety.
    HIV Med. 2018;19 Suppl 1:63-65.
    PubMed     Text format     Abstract available


  69. POWER L, Hows J, Jakobsen SF
    Key findings on legal and regulatory barriers to HIV testing and access to care across Europe.
    HIV Med. 2018;19 Suppl 1:58-62.
    PubMed     Text format     Abstract available


  70. ANAGNOSTOU O, Fotiou A, Kanavou E, Antaraki A, et al
    Factors associated with HCV test uptake in heroin users entering substitution treatment in Greece.
    HIV Med. 2018;19 Suppl 1:34-39.
    PubMed     Text format     Abstract available


  71. SCHWEITZER AM, Bogdan M, Corduneanu A, Ciocea I, et al
    Role of pretest counseling sessions on increasing subjective knowledge about HIV and hepatitis transmission among the beneficiaries of a free of charge, voluntary counseling and testing program in Constanta, Romania.
    HIV Med. 2018;19 Suppl 1:66-70.
    PubMed     Text format     Abstract available


  72. CROXFORD S, Burns F, Copas A, Pharris A, et al
    Factors associated with delayed linkage to care following HIV diagnosis in the WHO European Region.
    HIV Med. 2018;19 Suppl 1:40-46.
    PubMed     Text format     Abstract available


  73. FERNANDEZ-LOPEZ L, Reyes-Uruena J, Agusti C, Kustec T, et al
    The COBATEST network: monitoring and evaluation of HIV community-based practices in Europe, 2014-2016.
    HIV Med. 2018;19 Suppl 1:21-26.
    PubMed     Text format     Abstract available


  74. RUUTEL K, Lemsalu L, Latt S
    Monitoring HIV-indicator condition guided HIV testing in Estonia.
    HIV Med. 2018;19 Suppl 1:47-51.
    PubMed     Text format     Abstract available


  75. HOYOS J, Mate T, Indave BI, Agusti C, et al
    Knowledge, actual and potential use of HIV self-sampling testing kits among MSM recruited in eight European countries.
    HIV Med. 2018;19 Suppl 1:27-33.
    PubMed     Text format     Abstract available


  76. PLATTEAU T, van Lankveld J, Apers L, Fransen K, et al
    HIV testing for key populations in Europe: A decade of technological innovation and patient empowerment complement the role of health care professionals.
    HIV Med. 2018;19 Suppl 1:71-76.
    PubMed     Text format     Abstract available


  77. RUUTEL K, Kallavus K, Tomera I
    Monitoring anonymous HIV testing in Estonia from 2005 to 2015.
    HIV Med. 2018;19 Suppl 1:16-20.
    PubMed     Text format     Abstract available


  78. BRADSHAW D, Rae C, Rayment M, Turner N, et al
    HIV/HCV/HBV testing in the emergency department: a feasibility and seroprevalence study.
    HIV Med. 2018;19 Suppl 1:52-57.
    PubMed     Text format     Abstract available


    January 2018
  79. CICCULLO A, Gagliardini R, Baldin G, Borghetti A, et al
    An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy.
    HIV Med. 2018 Jan 29. doi: 10.1111/hiv.12597.
    PubMed     Text format     Abstract available


  80. BISCHOFF J, Mauss S, Cordes C, Lutz T, et al
    Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
    HIV Med. 2018 Jan 25. doi: 10.1111/hiv.12579.
    PubMed     Text format     Abstract available


  81. KRENTZ HB, Campbell S, Gill VC, Gill MJ, et al
    Patient perspectives on de-simplifying their single-tablet co-formulated antiretroviral therapy for societal cost savings.
    HIV Med. 2018 Jan 25. doi: 10.1111/hiv.12578.
    PubMed     Text format     Abstract available


  82. DI CARLOFELICE M, Everitt A, Muir D, Winston A, et al
    Cerebrospinal fluid HIV RNA in persons living with HIV.
    HIV Med. 2018 Jan 25. doi: 10.1111/hiv.12594.
    PubMed     Text format     Abstract available


  83. LIU Z, Fang Q, Zuo J, Minhas V, et al
    The world-wide incidence of Kaposi's sarcoma in the HIV/AIDS era.
    HIV Med. 2018 Jan 25. doi: 10.1111/hiv.12584.
    PubMed     Text format     Abstract available


  84. PUFALL EL, Kall M, Shahmanesh M, Nardone A, et al
    Sexualized drug use ('chemsex') and high-risk sexual behaviours in HIV-positive men who have sex with men.
    HIV Med. 2018 Jan 24. doi: 10.1111/hiv.12574.
    PubMed     Text format     Abstract available


  85. KWAN N, Wong A, Fang Y, Wang Z, et al
    'Get an early check - Chrysanthemum tea': An outcome evaluation of a multimedia campaign promoting HIV testing among men who have sex with men in Hong Kong.
    HIV Med. 2018 Jan 24. doi: 10.1111/hiv.12583.
    PubMed     Text format     Abstract available


  86. KENT L, Amlani A, Vundavalli S, Ridha BH, et al
    Clinical use of brain magnetic resonance imaging for neurological symptoms in people living with HIV.
    HIV Med. 2018 Jan 19. doi: 10.1111/hiv.12580.
    PubMed     Text format    


  87. AEBI-POPP K, Mercanti V, Voide C, Nemeth J, et al
    Neglect of attention to reproductive health in women with HIV infection: contraceptive use and unintended pregnancies in the Swiss HIV Cohort Study.
    HIV Med. 2018 Jan 16. doi: 10.1111/hiv.12582.
    PubMed     Text format     Abstract available


  88. PETERS H, Thorne C, Tookey PA, Byrne L, et al
    National audit of perinatal HIV infections in the UK, 2006-2013: what lessons can be learnt?
    HIV Med. 2018 Jan 16. doi: 10.1111/hiv.12577.
    PubMed     Text format     Abstract available


    December 2017
  89. LAHER A, Ariefdien N, Etlouba Y
    HIV prevalence among first-presentation psychotic patients.
    HIV Med. 2017 Dec 28. doi: 10.1111/hiv.12575.
    PubMed     Text format     Abstract available


  90. ROEN A, Laut K, Pelchen-Matthews A, Borodulina E, et al
    Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort.
    HIV Med. 2017 Dec 22. doi: 10.1111/hiv.12573.
    PubMed     Text format     Abstract available


  91. ROSENTHAL E, Fougerou-Leurent C, Renault A, Carrieri MP, et al
    Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).
    HIV Med. 2017 Dec 7. doi: 10.1111/hiv.12571.
    PubMed     Text format     Abstract available


  92. MUKANYANGEZI MF, Sengpiel V, Manzi O, Tobin G, et al
    Screening for human papillomavirus, cervical cytological abnormalities and associated risk factors in HIV-positive and HIV-negative women in Rwanda.
    HIV Med. 2017 Dec 6. doi: 10.1111/hiv.12564.
    PubMed     Text format     Abstract available


  93. BASHIR T, Reddy K
    HbAHP-25 attenuates HIV-1 gp120 mediated inflammation and barrier dysfunction.
    HIV Med. 2017 Dec 6. doi: 10.1111/hiv.12569.
    PubMed     Text format     Abstract available


  94. SMOLDERS EJ, Smit C, de Kanter C, Dofferhoff A, et al
    Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.
    HIV Med. 2017 Dec 1. doi: 10.1111/hiv.12570.
    PubMed     Text format     Abstract available


  95. STIRRUP OT, Copas AJ, Phillips AN, Gill MJ, et al
    Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion.
    HIV Med. 2017 Dec 1. doi: 10.1111/hiv.12567.
    PubMed     Text format     Abstract available


    November 2017
  96. UTHAPPA CK, Allam RR, Pant R, Pal S, et al
    Pre-exposure prophylaxis: awareness, acceptability and risk compensation behaviour among men who have sex with men and the transgender population.
    HIV Med. 2017 Nov 27. doi: 10.1111/hiv.12572.
    PubMed     Text format     Abstract available


  97. ELGALIB A, Fidler S, Sabapathy K
    Hospital-based routine HIV testing in high-income countries: a systematic literature review.
    HIV Med. 2017 Nov 23. doi: 10.1111/hiv.12568.
    PubMed     Text format     Abstract available


  98. JAO J, Yu W, Patel K, Miller TL, et al
    Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.
    HIV Med. 2017 Nov 21. doi: 10.1111/hiv.12566.
    PubMed     Text format     Abstract available


  99. KOWALSKA JD, Aebi-Popp K, Loutfy M, Post FA, et al
    Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group.
    HIV Med. 2017 Nov 21. doi: 10.1111/hiv.12565.
    PubMed     Text format     Abstract available


  100. YOUNG J, Smith C, Teira R, Reiss P, et al
    Antiretroviral pill count and clinical outcomes in treatment-naive patients with HIV infection.
    HIV Med. 2017 Nov 6. doi: 10.1111/hiv.12562.
    PubMed     Text format     Abstract available


  101. HUFF H, Merchant AT, Lonn E, Pullenayegum E, et al
    Vitamin D and progression of carotid intima-media thickness in HIV-positive Canadians.
    HIV Med. 2017 Nov 6. doi: 10.1111/hiv.12563.
    PubMed     Text format     Abstract available


  102. AIBIBULA W, Cox J, Hamelin AM, Moodie E, et al
    Food insecurity may lead to incomplete HIV viral suppression and less immune reconstitution among HIV/hepatitis C virus-coinfected people.
    HIV Med. 2017 Nov 2. doi: 10.1111/hiv.12561.
    PubMed     Text format     Abstract available



  103. A note of thanks to referees for Volume 18, 2017.
    HIV Med. 2017;18:793-795.
    PubMed     Text format    


    October 2017
  104. DE WIT S, Battegay M, D'Arminio Monforte A, Lundgren JD, et al
    European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16-17 November 2016: a summary.
    HIV Med. 2017 Oct 27. doi: 10.1111/hiv.12559.
    PubMed     Text format     Abstract available


  105. COZZI-LEPRI A, Zangerle R, Machala L, Zilmer K, et al
    Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.
    HIV Med. 2017 Oct 6. doi: 10.1111/hiv.12557.
    PubMed     Text format     Abstract available


  106. FUREGATO M, Mitchell H, Ogaz D, Woodhall S, et al
    The role of frequent HIV testing in diagnosing HIV in men who have sex with men.
    HIV Med. 2017 Oct 6. doi: 10.1111/hiv.12558.
    PubMed     Text format     Abstract available


    March 2017
  107. TRON L, Lert F, Spire B, Dray-Spira R, et al
    Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.
    HIV Med. 2017;18:181-195.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: